Skip to main content
Stavros Stavrakis, MD, Cardiology, Oklahoma City, OK

Stavros Stavrakis MD

Cardiac Electrophysiology


Associate Professor, Medicine, University of Oklahoma College of Medicine

Join to View Full Profile
  • 825 NE 10th StOklahoma City, OK 73104

  • Phone+1 405-271-7001

  • Fax+1 405-271-3064

Dr. Stavrakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterFellowship, Clinical Cardiac Electrophysiology, 2011 - 2012
  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterFellowship, Cardiovascular Disease, 2008 - 2011
  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 2005 - 2008
  • University of Athens
    University of AthensClass of 2003

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2007 - 2025
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Clinical Cardiac Electrophysiology
    American Board of Internal Medicine Clinical Cardiac Electrophysiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Efficacy of Coronary Sinus Reducer in Patients with Refractory Angina—A Systematic Review of the Literature  
    Stavros Stavrakis, MD, Journal of Interventional Cardiology

Authored Content

  • A Potential Relationship Between Gut Microbes and Atrial Fibrillation: Trimethylamine N-oxide, a Gut Microbe-Derived Metabolite, Facilitates the Progression of Atrial FibrillationFebruary 2018

Press Mentions

  • A Ground-Breaking Clinical Trial Using Parasym(TM) Neuromodulation Device Opens Potential New Era of Treatment for Heart Failure
    A Ground-Breaking Clinical Trial Using Parasym(TM) Neuromodulation Device Opens Potential New Era of Treatment for Heart FailureApril 21st, 2022
  • OU Health Doctor Explains Risk of Myocarditis with COVID-19 Vaccine Versus COVID-19 Virus
    OU Health Doctor Explains Risk of Myocarditis with COVID-19 Vaccine Versus COVID-19 VirusSeptember 1st, 2021
  • Smartphone ECG Screening App Aided Detection of AF Among American Indians
    Smartphone ECG Screening App Aided Detection of AF Among American IndiansApril 24th, 2021
  • Join now to see all

Grant Support

  • Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillationUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR2022–2026
  • Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillationUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR2022–2026
  • Addressing Health Disparities among Oklahoma Minority and Rural Communities through Clinical Research Education and Career DevelopmentUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR2017–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: